ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Cognitive Behavior Therapy for Treating Anxiety in People With Dementia

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Cognitive Behavior Therapy for Treating Anxiety in People With Dementia
Official Title  Cognitive Behavior Therapy for Anxiety in Dementia
Brief Summary

This study will evaluate the effectiveness of cognitive behavioral therapy in treating anxiety in older adults with dementia.

Detailed Description

Dementia is an illness that causes memory problems; changes in behavior; and difficulty with thinking, making decisions, and carrying out daily activities. Many people with dementia also have anxiety, and yet very little is known about effective treatment strategies for anxiety in this population. Cognitive behavioral therapy (CBT) is a type of psychotherapy that is commonly used to treat anxiety. CBT involves teaching patients skills to help them manage their anxiety, such as relaxation, changing their thoughts, and problem-solving. This study will evaluate the effectiveness of CBT in treating anxiety in older adults with dementia. In addition, the study will determine the effect of the treatment on patients' families and friends, and how families and friends may be able to help patients manage their anxiety. All study participants will name a family member or friend who will also participate in the study.

All participants in this study will answer a preliminary set of questions about anxiety and memory and will then complete a number of activities that involve learning and memory. These evaluations will take approximately 45 minutes. Participants who are selected to continue in the study will answer a second set of questions about mood, memory, concentration, and how they are doing in certain areas of life. These interview questions will take place during 2 sessions and will last a total of approximately 3 hours. Participants will then be randomly assigned to receive either enhanced usual care (EUC) or 8 to 10 sessions of CBT over a period of 10 to 12 weeks. Each CBT session will last about 1 hour and will include meeting with a study staff member to discuss anxiety and how to cope with it. Participants will also complete practice activities at home for about 20 minutes per day. EUC will consist of regular ongoing care from healthcare providers and phone assessments at 1-month and 2-month. Following the 6 month assessment, participants in EUC will be offered a half-day Cognitive Behavior Workshop. Enhanced usual care will consist of regular ongoing care from healthcare providers and biweekly phone calls for 3 months, followed by monthly phone calls for the next 3 months. Some of the pretreatment questions will be asked again immediately after the treatment period has been completed and again 3 months later for all participants.

Study Phase Phase I
Study Type  Interventional
Study Design  Treatment, Randomized, Single Blind (Outcomes Assessor), Historical Control, Single Group Assignment, Efficacy Study
Primary Outcome Measure  Rating Anxiety in Dementia (RAID) and Neuropsychiatric Inventory (NPI)- Anxiety subscales [ Time Frame: Measured at pre-treatment, post-treatment, and 3-month follow-up ] [ Designated as safety issue: No ]
Structured Interview Guide for the Hamilton Anxiety Scale (SIGH-A) [ Time Frame: Measured at pre-treatment, post-treatment, and 3-month follow-up ] [ Designated as safety issue: No ]
Secondary Outcome Measure  Quality of Life in Alzheimer's Disease (QOL-AD) [ Time Frame: Measured at pre-treatment, post-treatment, and 3-month follow-up ] [ Designated as safety issue: No ]
Geriatric Depression Scale (GDS) [ Time Frame: Measured at pre-treatment, post-treatment, and 3-month follow-up ] [ Designated as safety issue: No ]
Penn State Worry Questionnaire (PSWQ) [ Time Frame: Measured at pre-treatment, post-treatment, and 3-month follow-up ] [ Designated as safety issue: No ]
Geriatric Anxiety Inventory (GAI) [ Time Frame: Measured at pre-treatment, post-treatment, and 3-month follow-up ] [ Designated as safety issue: No ]
Condition  Anxiety Disorders
Dementia
Intervention  Behavioral: Cognitive Behavioral Therapy of Anxiety in Dementia (CBT-AD)
Behavioral: Enhanced Usual Care (EUC)
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  50
Start Date  January 2008
Completion Date June 2010
Eligibility Criteria 

Inclusion Criteria:

  • Alzheimer's disease that is in the mild or moderate range according to a score of 0.5 to 2.0 on the Clinical Dementia Rating (CDR) Scale
  • Significant anxiety as defined by a score of 4 on the Neuropsychiatric Inventory (NPI)
  • Agrees to permit participation of a collateral
  • English-speaking

Exclusion Criteria:

  • Suicidal intent
  • Current psychosis or bipolar disorder
  • History of substance abuse within 1 month prior to study entry
Gender Both
Ages 60 Years and older
Accepts Healthy Volunteers No
Contacts ††
Contact: Jessica Calleo, PhD     713-794-8521     jcalleo@bcm.tmc.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00596284
Organization ID R34 MH078925
Secondary IDs †† DATR A4-GPS
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     Melinda A. Stanley, PhD     Baylor College of Medicine    
Study Director:     Jessica Calleo, PhD     Baylor College of Medicine    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date August 2008
First Received Date  January 4, 2008
Last Updated Date August 26, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers